Azacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed By Surgery

Stopped Slow Accrual due to patients not wanting daily clinic administration of 5AZA and/or 6 months of treatment after surgery.

Conditions

• Stage IA Non-Small Cell Lung Carcinoma
• Stage IB Non-Small Cell Lung Carcinoma

Interventions

• DRUG: Azacitidine
• DRUG: Entinostat
• OTHER: Laboratory Biomarker Analysis

Sponsor

National Cancer Institute (NCI)